Intravitreal injection of triamcinolone acetonide for evere vitriti in patient with incomplete Behcetʹ dieae

Purpoe To report our experience with intravitreal triamcinolone acetonide (IVTA) injection for the treatment of ight-threatening vitriti. Deign Interventional cae erie. Method Three patient with acute evere exacerbation of noninfectiou panuveiti and vitriti were treated with IVTA injection alone or a an adjunct to ytemic immunouppreive agent. Reult Rapid clearance of the vitreou inflammation with improvement in viual acuity wa oberved 1 to 2 week after injection. The effect lated 2 to 6 month, with the hortet duration in the vitrectomized eye of Patient 1. Repeated injection were required in all patient. Concluion Intravitreal triamcinolone acetonide may be beneficial in elected cae of vitriti. Thi treatment modality ha a rapid effect and may lower the ue of ytemic agent.